The application of physiologically based pharmacokinetic modelling in the analysis of occupational exposure to perchloroethylene.

A physiologically based pharmacokinetic model for perchloroethylene was parameterized, calibrated and validated using anatomic, physiologic, biochemical and physicochemical data obtained from the literature. The model was used to analyse human exposure data obtained under controlled conditions and from dry cleaning establishments in the Padua area of northern Italy. Whilst the model satisfactorily simulated the urinary excretion of trichloroacetic acid, following experimental inhalation exposure to 10, 20 and 40 ppm perchloroethylene under controlled conditions the opposite was true for the occupational exposure data. However, further model refinement to incorporate inter-individual variability of anatomical, physiological and biochemical parameters which have an impact on model output, would further improve the predictive capabilities of the model. The possibility of perchloroethylene and trichloroethylene co-exposure in the occupational setting was indicated by the model.

[1]  Richard D. Stewart,et al.  ABSORPTION OF CARBON TETRACHLORIDE, TRICHLOROETHYLENE, TETRACHLOROETHYLENE, METHYLENE CHLORIDE, AND 1,1,1-TRICHLOROETHANE THROUGH THE HUMAN SKIN. , 1964 .

[2]  P J Lioy,et al.  A distributed parameter physiologically-based pharmacokinetic model for dermal and inhalation exposure to volatile organic compounds. , 1995, Risk analysis : an official publication of the Society for Risk Analysis.

[3]  R. S. Thomas,et al.  Approaches to developing alternative and predictive toxicology based on PBPK/PD and QSAR modeling. , 1998, Environmental health perspectives.

[4]  M Rowland,et al.  Physiologic pharmacokinetic models and interanimal species scaling. , 1985, Pharmacology & therapeutics.

[5]  M. Pieters,et al.  Evaluation of the uncertainty factor for subchronic-to-chronic extrapolation: statistical analysis of toxicity data. , 1998, Regulatory toxicology and pharmacology : RTP.

[6]  E. Gubéran,et al.  Experimental human exposures to tetrachloroethylene vapor and elimination in breath after inhalation. , 1976, American Industrial Hygiene Association journal.

[7]  W. T. Berge,et al.  Two mathematical skin permeation models for vapours , 1995 .

[8]  W. Dekant,et al.  Biotransformation, excretion and nephrotoxicity of haloalkene-derived cysteine S-conjugates , 1997, Archives of Toxicology.

[9]  H J Clewell,et al.  The application of physiologically based pharmacokinetic modeling in human health risk assessment of hazardous substances. , 1995, Toxicology letters.

[10]  M. Andersen,et al.  The use of biochemical and molecular parameters to estimate dose-response relationships at low levels of exposure. , 1998, Environmental health perspectives.

[11]  H V Rao,et al.  A physiologically based pharmacokinetic assessment of tetrachloroethylene in groundwater for a bathing and showering determination. , 1993, Risk analysis : an official publication of the Society for Risk Analysis.

[12]  H J Clewell,et al.  Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE). , 1993, Toxicology letters.

[13]  D. D. Bois,et al.  CLINICAL CALORIMETRY: TENTH PAPER A FORMULA TO ESTIMATE THE APPROXIMATE SURFACE AREA IF HEIGHT AND WEIGHT BE KNOWN , 1916 .

[14]  P. Droz,et al.  Ethnic differences in biological monitoring of several organic solvents. I. Human exposure experiment , 1997, International archives of occupational and environmental health.

[15]  M E Andersen,et al.  A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. , 1984, Toxicology and applied pharmacology.

[16]  M E Andersen,et al.  Physiological modelling of organic compounds. , 1991, The Annals of occupational hygiene.

[17]  Melvin E. Andersen,et al.  Gas Uptake Inhalation Techniques and the Rates of Metabolism of Chloromethanes, Chloroethanes, and Chloroethylenes in the Rat , 1990 .

[18]  H J Clewell,et al.  Dermal absorption of organic chemical vapors in rats and humans. , 1990, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[19]  H J Clewell,et al.  Physiologically based pharmacokinetic modeling of the pregnant rat: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. , 1989, Toxicology and applied pharmacology.

[20]  C B Frederick,et al.  Limiting the uncertainty in risk assessment by the development of physiologically based pharmacokinetic and pharmacodynamic models. , 1993, Toxicology letters.

[21]  H J Clewell,et al.  Applying simulation modeling to problems in toxicology and risk assessment--a short perspective. , 1995, Toxicology and applied pharmacology.

[22]  M. Gargas,et al.  In Vivoandin VitroStudies of Perchloroethylene Metabolism for Physiologically Based Pharmacokinetic Modeling in Rats, Mice, and Humans , 1996 .

[23]  Melvin E. Andersen,et al.  Physiologically-Based Pharmacokinetic Modeling* , 1994 .

[24]  D Krewski,et al.  Uncertainty, variability, and sensitivity analysis in physiological pharmacokinetic models. , 1995, Journal of biopharmaceutical statistics.

[25]  V. Fiserova-Bergerova,et al.  Predictable "individual differences" in uptake and excretion of gases and lipid soluble vapours simulation study. , 1980, British journal of industrial medicine.

[26]  G. W. Jepson,et al.  Determination of Skin:Air Partition Coefficients for Volatile Chemicals: Experimental Method and Applications , 1994 .

[27]  E. Lederer,et al.  Biotransformation of perchloroethene: dose-dependent excretion of trichloroacetic acid, dichloroacetic acid, and N-acetyl-S-(trichlorovinyl)-L-cysteine in rats and humans after inhalation. , 1998, Toxicology and applied pharmacology.

[28]  J W Fisher,et al.  A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol. , 1998, Toxicology and applied pharmacology.

[29]  A C Monster,et al.  Kinetics of tetrachloroethylene in volunteers; influence of exposure concentration and work load , 1979, International archives of occupational and environmental health.

[30]  B C Allen,et al.  Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans. , 1993, Risk analysis : an official publication of the Society for Risk Analysis.

[31]  W. Dekant,et al.  Gas-uptake pharmacokinetics of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123). , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[32]  J. Kraner,et al.  Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. , 1993, Critical reviews in toxicology.